Making Liquid Biopsy Work for the NHS: The Potential of Long-Read Sequencing
Wednesday, January 27, 2027 at 4:30 PM to 5:00 PM · 30 min. (Europe/London)
Cancer Diagnostics Stage
Day 1 - Wednesday 27th January
Cancer DiagnosticsLiquid BiopsySequencing
Information
This session will cover:
- Seeing more in a blood sample: How long-read sequencing can combine mutations, fragmentomics, methylation and nucleosome footprints to create a richer picture of cancer.
- From research to clinical application: Insights from translating multimodal liquid biopsy into clinical trials, including its potential to help stratify patients presenting with abdominal pain.
- Bringing down the cost of cancer testing: How a low-cost liquid biopsy assay could make testing more accessible and scalable across the NHS.
- Scaling beyond the laboratory: The infrastructure, clinical pathways and centralised testing models needed to bring liquid biopsy into routine NHS care.
